
Last updated: 2026-09-06 01:36:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Advanced Biomed Inc. (ADVB) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $9.32, with a market capitalization of $16.14M and a P/E ratio of 2.94. Over the past 52 weeks, its price has ranged from $3.61 to $24.23. This page covers its latest market performance, valuation, price trends and company information.
$16.14M | |
$9.24 | |
$82.00 | |
$3.61 | |
$9.40 | |
58.07K | |
-- | |
2.94 | |
$24.23 | |
$3.61 | |
-- | |
-- |
Advanced Biomed Inc. (ADVB) last closed at $9.40 as of 2026-09-04 20:39:00, unchanged from the previous close of $9.40.
During the latest regular trading session, ADVB traded between $3.61 and $82.00, with a volume of 58.07K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Advanced Biomed Inc. (ADVB) moved from $9.54 to $9.32, representing a decline of 2.36% ($0.22).
The stock traded between $9.16 and $9.44 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 218.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27.7%
ADVB is currently trading at $9.32, placing it 27.7% of the way from its 52-week low of $3.61 to its 52-week high of $24.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 31 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Advanced Biomed Inc. (ADVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.